Pharma Marketing News is the monthly newsletter of the Pharma Marketing Network. It is distributed FREE to registered subscribers via email and the Web.
Editorial & Advisory Board
We accept advertising relevant to the interests of our subscribers.
For more information, see:
PO Box 760
Newtown, PA 18940
The First Forum for Pharmaceutical Marketing Experts
Pharma Marketing News e-Newsletter |
Pharma Marketing Online Discussion Forum
Case Studies |
Pharma Marketing Blog
Pharma Marketers Vendor Directory |
Conference Calendar |
Advertising Information |
About Us |
Subscribe to Pharma Marketing News today and enjoy the following FREE benefits!
Preview of January Issue
Each issue of Pharma Marketing News is packed with
facts, opinions, and case studies based upon interviews with experts in the
field of pharmaceutical marketing. Highlights of presentations from industry
conferences, contact lists of experts consulted, and links to references help
subscribers keep up to date on best practices and network with their peers. Your subscription includes:
- The monthly Pharma Marketing News e-newsletter, delivered to you by e-mail, is packed with research data, expert opinions, and product/service reviews.
- Option to join the Pharma Marketing Forum -- the FIRST online networking community and interactive discussion group for pharmaceutical marketers.
- List your company in the Vendor Directory.
- Receive highly relevant information about industry conferences, jobs, and products and services.
Sample Articles from Previous Issues of Pharma Marketing News
Here are some popular articles from past issues of Pharma Marketing News. We hope you enjoy reading them and find them informative.
- The Indian Pharmaceutical Market
The Indian pharmaceutical market is the world's fourth largest by volume (8% of global total) and thirteenth largest by value (less than 1% of global total). Although prices are the lowest in the world, 70% of the population does not have access to drug therapy and 2002 per capita consumption was only $3.33. The lack of pharmaceutical patents means that there is an average of 200 brands for every molecule on the market. Full text PDF
- Will COX-2 Inhibitors Crash and Burn?
Is the sky falling around COX-2 inhibitors?
After the fall of Vioxx, Merck is suffering mightily: 42% loss of market share, downgraded credit ratings, lost revenue, congressional scrutiny, etc. But worse still, the entire class of COX-2 inhibitors is under increased scrutiny and the credibility of Merck, the FDA, and the entire drug industry is in question as revelations about who knew what, when are announced almost daily.
This article documents the effect of the withdrawal of Vioxx and other COX-2 revelations on physicians' prescribing behavior using data from ImpactRx. Also included are results from a recent survey we conducted of Pharma Marketing News susbcribers regarding the wisdom of Pfizer's decision to test Celebrex to see if it is able to prevent heart attacks and strokes in patients with serious cardiovascular disease. Full text PDF
- Results from FDA Physician Survey on DTC Advertising
This article reviews a presentation by Kathryn Aikin of DDMAC/FDA in which she disclosed preliminary results from the FDA's Physician Survey, which looked at the impact of DTC advertising on the doctor-patient relationship.The survey profiled 250 GP's and 250 specialists (dermatology, allergy/pulmonology, endocrinology, and psychiatry) from a random sample of the AMA Physician Masterfile, which includes a list of all U.S. medical school graduates. Full text PDF